The popularity of Viagra initially drove a surge for major pharmaceutical companies, however recent developments present a uncertain outlook for investors. Lower-cost alternatives are eating into revenue, and continued https://umarhici670147.blogdomago.com/39704755/sildenafil-and-the-pharmaceutical-industry-a-precarious-investment